| Order |
Research name |
Owner and participants of the publications or journals |
Publications or journals published |
| 1 |
Clinical outcomes and mortality risk factors among intensive care unit patients with bacteremia at a university hospital. |
Santimaleeworagun W, Wacharasint P, Saelim W, Suphanklang J, Duangmee K, Ruenroengbun N, Thiengkumdee P, Ratchadawan S, Tewthao D, Kulkiatprasert T. |
Science, Engineering and Health Studies (SEHS). 15: 21050008; Jul 2021. (Scopus) |
| 2 |
Evaluation of the cost-utility of phosphate binders as a treatment option for hyperphosphatemia in chronic kidney disease patients: A systematic review and meta-analysis of the economic evaluations |
Chaiyakittisopon M, Pattanaprateep O, Ruenroengbun N, Sapankaew T, Ingsathit A, Mckay G.J, Attia J, Thakkinstian A.
|
The European Journal of Health Economics. 22: 571–584; Mar 2021. (ISI, Scopus) |
| 3 |
Efficacy and safety of conventional antiviral agents in preventive strategies for cytomegalovirus infection after kidney transplantation: A systematic review and network meta-analysis |
Ruenroengbun N, Numthavaj P, Sapankaew T, Chaiyakittisopon K, Ingsathit A, Mckay G.J, Attia J, Thakkinstian A.
|
Transplant International. 2021: 1-15; Sep 2021. (ISI, Scopus) |
| 4 |
Efficacy and safety of immunomodulators in patients with COVID-19: A systematic review and network meta-analysis of randomized controlled trials
|
Ngamprasertchai T, Kajeekul R, Sivakorn C, Ruenroegnboon N, Luvira V, Siripoon T, Luangasanatip N. |
Infectious Diseases and Therapy. 10(4): 1-18; Dec 2021. (ISI, Scopus) |
| 5 |
Efficacy and safety of antiviral agents in proventing allograft rejection following CMV prophylaxis in high-risk kidney transplantationi: A systematic review and network meta-analysis of randomized controlled trials
|
Ruengroengbun N, Sapankaew T, Chaiyakittisopon K, Phoompoung P, Ngamprasertchai T. |
Frontiers in Cellular and Infection Microbiology. 12: Article 865735; Apr 2022. (ISI, Scopus) |
| 6 |
Efficacy and safety of antiviral agents in proventing allograft rejection following CMV prophylaxis in high-risk kidney transplantationi: A systematic review and network meta-analysis of randomized controlled trials |
Ruengroengbun N, Sapankaew T, Chaiyakittisopon K, Phoompoung P, Ngamprasertchai T. |
Frontiers in Cellular and Infection Microbiology. 12: 865735; Apr 2022. (ISI, Scopus)
|
| 7 |
Efcacy and safety of urate-lowering agents in asymptomatic hyperuricemia: Systematic review and network meta-analysis of randomized controlled trials
|
Sapankaew T, Thadanipon K, Ruenroengbun N, Chaiyakittisopon K, Ingsathit A, Numthavaj P, Chaiyakunapruk N, McKay G, Attia J, Thakkinstian A. |
BMC Nephrology. 23: 223; Jun 2022. (ISI, Scopus) |
| 8 |
อุบัติการณ์และปัจจัยที่สัมพันธ์กับการเกิดภาวะเลือดออกในผู้ป่วยที่ได้รับยาละลายลิ่มเลือดร่วมกับยากลุ่มคอร์ติโคสเตียรอยด์
|
นริศา รื่นเริงบุญ, เกตน์สิรี คงสุวรรณ, มาลีวัลย์ ดอกแก้วกลาง, อภิชญา ลักขษร, อาภาภรณ์ อาจแสน, ปิยวรรณ ศรีมณี, ณัฐพงศ์ กาญจนะโกมล, กวิณ ด้วงมี |
วารสารไทยไภษัชยนิพนธ์. 19(1): 53-65; ม.ค.-มิ.ย. 2567. (TCI กลุ่ม 1) |
| 9 |
Streptokinase and premedication strategies: Incidence of type I hypersensitivity reactions associated with streptokinase in clinical practice |
Ruenroengbun N, Boonmuang P, Ruangin Y, Dussadeeworawet K, Tangboriboonphol T, Petchlor C, Srimanee P, Duangmee K. |
Science, Engineering and Health Studies. 17: 23050009; Dec 2023. (Scopus)
|
